Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
- DOI
- 10.1002/dta.3969
- Published
- 2025-11-16
- Container
- Drug Testing and Analysis
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/dta.3969,
title = {Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing},
author = {Zhongquan Li and Bing Liu and Yirang Wang and Jiahui Cheng and Rodrigo Aguilera and Xiaojun Deng and Qing Chen and Peijie Chen},
year = {2025},
journal = {Drug Testing and Analysis},
doi = {10.1002/dta.3969},
url = {https://doi.org/10.1002/dta.3969}
}RIS
TY - JOUR TI - Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing AU - Zhongquan Li AU - Bing Liu AU - Yirang Wang AU - Jiahui Cheng AU - Rodrigo Aguilera AU - Xiaojun Deng AU - Qing Chen AU - Peijie Chen PY - 2025 JO - Drug Testing and Analysis DO - 10.1002/dta.3969 UR - https://doi.org/10.1002/dta.3969 ER -
APA
Li, Z., Liu, B., Wang, Y., Cheng, J., Aguilera, R., Deng, X., Chen, Q., & Chen, P. (2025). Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing. Drug Testing and Analysis. https://doi.org/10.1002/dta.3969
Source records
- crossref · retrieved 2026-09-26T05:58:35.858Z